Quality of Life in Cardiac Arrest Recovery - Scorecard - MDSpire

Quality of Life in Cardiac Arrest Recovery

Post–cardiac arrest care is increasingly structured around survivorship, with standardized patient-reported assessments supporting multidisciplinary follow-up.

  • By

  • Kathryn Wighton

  • February 19, 2026

  • 4 min

Share

Clinical Scorecard: Quality of Life in Cardiac Arrest Recovery

At a Glance

CategoryDetail
ConditionIn-hospital and out-of-hospital cardiac arrest recovery
Key MechanismsHealth-related quality of life (HRQOL) linked to long-term survival
Target PopulationSurvivors of in-hospital cardiac arrest (IHCA) and out-of-hospital cardiac arrest (OHCA)
Care SettingPost-cardiac arrest recovery in clinical settings

Key Highlights

  • Poor HRQOL scores (11-25) linked to over twice the mortality risk in IHCA survivors
  • No significant mortality association for HRQOL scores (6-10) in IHCA survivors
  • Continuous HRQOL measures indicate increasing mortality risk with poorer self-reported health
  • Depressive symptoms negatively impact long-term survival in IHCA survivors
  • High missing data rates raise concerns about generalizability

Guideline-Based Recommendations

Diagnosis

  • Assess HRQOL using the EuroQoL 5-dimension 5-level tool 3 to 6 months post-arrest

Management

  • Consider HRQOL scores in follow-up care planning for cardiac arrest survivors

Monitoring & Follow-up

  • Monitor changes in HRQOL over time to guide recovery strategies

Risks

  • Be aware of increased mortality risk associated with poor HRQOL scores

Patient & Prescribing Data

Adult survivors of IHCA or EMS-treated OHCA

HRQOL assessment may inform individualized recovery plans

Clinical Best Practices

  • Utilize standardized follow-up questionnaires to evaluate HRQOL
  • Address depressive symptoms in post-cardiac arrest care

References

Original Source(s)

Quality of Life in Cardiac Arrest Recovery

  • by Kathryn Wighton

  • February 19, 2026

Related Content

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.